Management of Bone Metastases in Patients with Castration-Resistant Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|92|4|377-386

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.92, Iss.4, 2014-04, pp. : 377-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of castration‐resistant prostate cancer and bone metastases with radium‐223 dichloride

By  

INTERNATIONAL JOURNAL OF UROLOGICAL NURSING, Vol. 9, Iss. 1, 2015-03 ,pp. : 3-13

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2014-10 ,pp. : 307-312

Karger

Access to resources Recommend Favorite

New Strategies for Medical Management of Castration-Resistant Prostate Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-05 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

Metabolic syndrome in castration‐resistant prostate cancer patients treated with abiraterone

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1329-1338

John Wiley & Sons Inc

Access to resources Recommend Favorite

C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 266-271

Karger

Access to resources Recommend Favorite